Hepatocellular carcinoma, a unique tumor with a lack of biomarkers

Jose D. Debes, Enrique Carrera, Angelo Z. Mattos, Jhon E. Prieto, Andre Boonstra

Producción científica: Contribución a una revistaComentario/Debate

12 Citas (Scopus)


Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death worldwide. Interestingly, the great majority of individuals affected by the tumor have underlying liver disease, therefore narrowing the population to be screened. Still, however, there is a clear lack of blood biomarkers, and surveillance in those at risk is performed by frequent imaging of the liver. A variety of multinational collaborations are currently invested in finding biomarkers for HCC based on liver-produced proteins. A new approach with assessment of peripheral proteins might be necessary for the successful early detection of this malignancy.

Idioma originalInglés
Páginas (desde-hasta)786-787
Número de páginas2
PublicaciónAnnals of Hepatology
EstadoPublicada - 1 nov. 2019


Profundice en los temas de investigación de 'Hepatocellular carcinoma, a unique tumor with a lack of biomarkers'. En conjunto forman una huella única.

Citar esto